NEW YORK >> Packaged food makers and fast-food restaurants may ‌be forced to overhaul more of their products next year as ...

India's obesity drug market is experiencing rapid growth, driven by rising lifestyle diseases and the launch of blockbuster ...

A nationwide survey by the Alzheimer’s Association in 2025 found close to 4 in 5 Americans 45 and older want to know if they have Alzheimer’s before symptoms appear. And 91% said they would take a ...

The year-end combines biological sensitivity with behavioural disruption. Hormones that regulate ovulation & sperm production ...

The U.S. Food and Drug Administration has approved a weight-loss pill from Novo Nordisk ($NVO) that could speed up how appetite-suppressing drugs ...

DelveInsight's Ulcerative Colitis Market Insights report includes a comprehensive understanding of current treatment practices, ulcerative colitis emerging drugs, market share of individual therapies, ...

Using GLP-1s or considering it? New global research reveals social and psychological consequences for everyday lives.

The world of weight loss drugs can be confusing. There are so many types and brand names, and then there’s the big question: Does weight loss medication work? The short answer is yes. Weight loss ...

Oprah Winfrey says the disappearance of so-called food noise is one of the most amazing effects of her GLP-1 drug. Plus now ...

She expected her body to change when she started taking Zepbound. But nobody told her what might happen to her marriage.

The rapid adoption of GLP-1 weight loss medications — drugs like Novo Nordisk's Ozempic and Wegovy and Eli Lilly's Zepbound and Mounjaro — is reshaping how Americans eat and shop. It's also changing ...

LONDON, Dec 9 (Reuters) - Women with polycystic ovary syndrome are increasingly turning to blockbuster weight-loss drugs from Eli Lilly (LLY.N), opens new tab and Novo Nordisk (NOVOb.CO), opens new ...